(Q44516092)

3 December 2017

Zardaverine as a selective inhibitor of phosphodiesterase isozymes (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

21 October 2022

1 reference

ChEBI release 2020-05-28

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

21 October 2022

author name string

C. Schudt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1648920

21 October 2022

S. Winder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1648920

21 October 2022

B. Müller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1648920

21 October 2022

D. Ukena

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1648920

21 October 2022

language of work or name

English

0 references

publication date

1 June 1991

1 reference

3 December 2017

21 June 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1648920

full work available at URL

21 October 2022

https://api.elsevier.com/content/article/PII:000629529190694Z?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

https://api.elsevier.com/content/article/PII:000629529190694Z?httpAccept=text/plain

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

21 October 2022

published in

Biochemical Pharmacology

1 reference

3 December 2017

42

1 reference

3 December 2017

153-162

1 reference

3 December 2017

1

1 reference

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

3 December 2017

2

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

Is phosphodiesterase inhibition a relevant bronchospasmolytic principle?

21 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

Actions of the phosphodiesterase inhibitor zardaverine on guinea-pig ventricular muscle

21 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors

21 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

A model for the regulation of the calmodulin-dependent enzymes erythrocyte Ca2+-transport ATPase and brain phosphodiesterase by activators and inhibitors

21 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

An improved assay of cyclic 3',5'-nucleotide phosphodiesterases with QAE-Sephadex columns

21 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

45 Measurement of O2− production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils

21 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents

21 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets

21 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle

21 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

Differentiation between bronchodilation and universal adenosine antagonism among xanthine derivatives

21 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

Effects of enprofylline on A1 and A2 adenosine receptors

21 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility

21 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

Subclasses of cyclic AMP phosphodiesterase in cardiac muscle

21 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

The isoenzyme selectivity of AH 21-132 as an inhibitor of cyclic nucleotide phosphodiesterase activity

21 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90694-Z

21 October 2022

Identifiers

1 reference

3 December 2017

1 reference